The estimated Net Worth of Venkatraman Thyagarajan is at least $213 Thousand dollars as of 22 August 2016. Venkatraman Thyagarajan owns over 5,748 units of Varian Medical Systems stock worth over $213,268 and over the last 16 years Venkatraman sold VAR stock worth over $0.
Sign up
Venkatraman Thyagarajan VAR stock SEC Form 4 insiders trading
Venkatraman has made over 10 trades of the Varian Medical Systems stock since 2012, according to the Form 4 filled with the SEC. Most recently Venkatraman exercised 5,748 units of VAR stock worth $95,043 on 22 August 2016.
The largest trade Venkatraman's ever made was exercising 10,000 units of Varian Medical Systems stock on 3 February 2015 worth over $704,800. On average, Venkatraman trades about 2,542 units every 103 days since 2009. As of 22 August 2016 Venkatraman still owns at least 12,898 units of Varian Medical Systems stock.
You can see the complete history of Venkatraman Thyagarajan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Venkatraman Thyagarajan's mailing address?
Venkatraman's mailing address filed with the SEC is C/O VARIAN MEDICAL SYSTEMS, INC., 3100 HANSEN WAY, MAIL STOP E-327, PALO ALTO, CA, 94304-1030.
Insiders trading at Varian Medical Systems
Over the last 21 years, insiders at Varian Medical Systems have traded over $57,574,967 worth of Varian Medical Systems stock and bought 500 units worth $22,595 . The most active insiders traders include Kent J Thiry, Timothy E Guertin, and Dow R Wilson. On average, Varian Medical Systems executives and independent directors trade stock every 11 days with the average trade being worth of $181,124. The most recent stock trade was executed by Jesse Michael Bruff on 1 March 2021, trading 6,499 units of VAR stock currently worth $1,142,589.
What does Varian Medical Systems's logo look like?
Complete history of Venkatraman Thyagarajan stock trades at Varian Medical Systems
Varian Medical Systems executives and stock owners
Varian Medical Systems executives and other stock owners filed with the SEC include:
-
Dow Wilson,
Chief Executive Officer, Director -
Kolleen Kennedy,
President - Proton Solutions Division and Chief Growth Officer -
Chris Toth,
President, Chief Operating Officer -
R. Andrew Eckert,
Independent Chairman of the Board -
Jeffrey Balser,
Independent Director -
Judy Bruner,
Independent Director -
Anat Ashkenazi,
Independent Director -
Jean-Luc Butel,
Independent Director -
Regina Dugan,
Independent Director -
David Illingworth,
Independent Director -
Phillip Febbo,
Independent Director -
Michael Hutchinson,
Senior Vice President, Chief Legal Officer -
Francis Facchini,
President, Interventional Solutions Business -
Anshul Maheshwari,
Vice President, Treasurer and Investor Relations -
Michelle Le Beau,
Independent Director -
J. Michael Bruff,
Chief Financial Officer, Senior Vice President - Finance -
Magnus Momsen,
SVP, CAO, Corporate Controller -
Mark R Laret,
Director -
Jose Baselga,
Director -
John W Kuo,
SVP, Gen Counsel and Secretary -
Gary E Jr Bischoping,
SVP, Finance & CFO -
Susan L Bostrom,
Director -
Timothy E Guertin,
Director -
Clarence R Verhoef,
SVP, Finance, Corp Controller -
Venkatraman Thyagarajan,
Director -
Sunny Sanyal,
SVP and President, ICB -
Robert H Kluge,
Corporate Vice President -
Richard M Levy,
President and CEO -
Ruediger Naumann Etienne,
Director -
John Seely Brown,
Director -
Erich R Reinhardt,
Director -
Tai Yun Chen,
VP and Corporate Controller -
David W Jr Martin,
Director -
Steven A Leibel,
Director -
Kent J Thiry,
Director -
Allen S Lichter,
Director -
Samuel Hellman,
Director -
Crisanto C Raimundo,
Corporate Controller -
Terry R Lautenbach,
Director -
Joseph B Phair,
VP Admin,Gen Counsel,Secretary -
Elisha W Finney,
Corporate Vice President & CFO -
Kevin O'reilly,
SVP, President of Oncology Sys